Analysis on the Correlation Between RUNX3 Mislocalization and Epigenetic Parameters in Non-Small Cell Lung Cancer

被引：0
|
作者：
Liu, W. [1 ,2 ]
Huang, C. [1 ,3 ]
Shi, Y. [4 ,5 ]
Lu, J. [4 ]
Chen, X. [1 ,2 ,5 ]
机构：
[1] Fujian Med Univ, Grad Sch, Fuzhou, Fujian, Peoples R China
[2] Fujian Med Univ, Dept Thorac Surg, Fujian Canc Hosp, Clin Oncol Sch, Fuzhou, Fujian, Peoples R China
[3] Fujian Med Univ, Clin Oncol Sch, Lab Immunooncol, Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China
[4] Fujian Med Univ, Dept Pathol, Clin Oncol Sch, Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China
[5] Fuzhou Univ, Interdisciplinary Inst Med Engn, Fuzhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
runt-related transcription factor 3; promoter hypermethylation; non-small cell lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.02B.06
引用
收藏
页码：S438 / S439
页数：2
相关论文
共 50 条
  • [31] Allelotype of non-small cell lung cancer
    Neville, EM
    Stewart, MP
    Swift, A
    Liloglou, T
    Ross, H
    Gosney, JR
    Donnelly, RJ
    Field, JK
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 9 (03) : 533 - 539
  • [32] Non-small cell lung cancer in China
    Chen, Peixin
    Liu, Yunhuan
    Wen, Yaokai
    Zhou, Caicun
    CANCER COMMUNICATIONS, 2022, 42 (10) : 937 - 970
  • [33] Necitumumab for non-small cell lung cancer
    Greillier, Laurent
    Tomasini, Pascale
    Bariesi, Fabrice
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (08) : 1231 - 1239
  • [34] Staging of non-small cell lung cancer
    Heigener, D. F.
    Deppermann, K. -M.
    Sebastian, M.
    Reck, M.
    ONKOLOGE, 2011, 17 (08): : 679 - 683
  • [35] Anthacyclines in non-small cell lung cancer
    Pronzato, P
    Vigani, A
    Tognoni, A
    Vaira, F
    Canessa, P
    LUNG CANCER, 2001, 34 : S57 - S59
  • [36] Mobocertinib in non-small cell lung cancer
    Liu, Shengwu
    Lowder, Kristen E.
    DRUGS OF TODAY, 2022, 58 (11) : 523 - 530
  • [37] Cetuximab in non-small cell lung cancer
    Ademuyiwa, Foluso O.
    Hanna, Nasser
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (01) : 107 - 113
  • [38] Ifosfamide in non-small cell lung cancer
    Boni, C
    Zanelli, F
    ONCOLOGY, 2003, 65 : 50 - 54
  • [39] Gefitinib in non-small cell lung cancer
    Tamura, K
    Fukuoka, M
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (06) : 985 - 993
  • [40] Correlation of cancer stem cell markers and immune cell markers in resected non-small cell lung cancer
    Huang, Zhaoqin
    Yu, Haining
    Zhang, Jianbo
    Jing, Haiyan
    Zhu, Wanqi
    Li, Xiaolin
    Kong, Lingling
    Xing, Ligang
    Yu, Jinming
    Meng, Xiangjiao
    JOURNAL OF CANCER, 2017, 8 (16): : 3190 - 3197
12345